Andere Kunden interessierten sich auch für
![Biosensors for Emerging and Re-emerging Infectious Diseases]( "Biosensors for Emerging and Re-emerging Infectious Diseases")
Biosensors for Emerging and Re-emerging Infectious Diseases129,99 €![Infectious Diseases and Nanomedicine II]( "Infectious Diseases and Nanomedicine II")
Infectious Diseases and Nanomedicine II110,99 €![Infectious Diseases and Nanomedicine II]( "Infectious Diseases and Nanomedicine II")
Infectious Diseases and Nanomedicine II110,99 €![Infectious Diseases and Nanomedicine I]( "Infectious Diseases and Nanomedicine I")
Infectious Diseases and Nanomedicine I110,99 €![Infectious Diseases and Nanomedicine I]( "Infectious Diseases and Nanomedicine I")
Infectious Diseases and Nanomedicine I110,99 €![USS Haraden (DD-585)]( "USS Haraden (DD-585)")
USS Haraden (DD-585)32,99 €![USS Hall (DD-583)]( "USS Hall (DD-583)")
USS Hall (DD-583)32,99 €
High Quality Content by WIKIPEDIA articles! The National Emerging Infectious Diseases Laboratories, or NEIDL, is a biosciences facility in Boston, Massachusetts, affiliated with Boston University. The lab is part of a national network of secure facilities that study infectious diseases, whether naturally occurring or introduced through bioterrorism. The Labs will include a BSL-4 laboratory. On February 2, 2006, Boston Medical Center received regulatory approval from the federal government to fund construction of a biosafety laboratory on its medical campus in Boston. There has been strong community opposition to the planned building, and several times the construction has been halted due to court injunctions.